Ipratropium: Difference between revisions
Ajgausepohl (talk | contribs) (edits) |
Ajgausepohl (talk | contribs) (edits) |
||
| Line 15: | Line 15: | ||
==Special Populations== | ==Special Populations== | ||
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: | *[[Drug Ratings in Pregnancy|Pregnancy Rating]]: B | ||
*Lactation: | *[[Lactation risk categories]]: L3 | ||
*Renal Dosing | *Renal Dosing - none | ||
*Hepatic Dosing - none | |||
*Hepatic Dosing | |||
==Contraindications== | ==Contraindications== | ||
Revision as of 01:00, 2 June 2015
General
- Type: Anticholinergic Agent
- Dosage Forms: Oral inhalation
- Common Trade Names: Atrovent
Adult Dosing
Asthma: 0.5mg Nebulized q20min, up to 3 doses
COPD: 0.5mg Nebulized q20mins, up to 3 doses
Pediatric Dosing
- Children ≤5 years: 0.25 mg Neb q20mins, up to 3 doses
- Children ≤12 years: 0.25-0.5 mg Neb q20mins, up to 3 doses
- Children >12 years: Refer to adult dosing
Special Populations
- Pregnancy Rating: B
- Lactation risk categories: L3
- Renal Dosing - none
- Hepatic Dosing - none
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action: